Blog post
The platform for antibody and protein R&D
Antibody programs are getting more complex. Formats are multiplying, wet and dry lab teams need the same data, and AI pilots fail when the foundation is wrong. Benchling gives antibody R&D teams the structured, connected platform to move from sequence to candidate faster.
One platform for antibody R&D, from discovery to development
Hundreds of biopharma teams use Benchling to run antibody programs from hit to candidate. Benchling Biologics brings an antibody-aware data model, no-code format configuration, and automated registration so every sequence is structured, connected, and ready for the work that comes next. All sequences, samples, and results live in one platform, with full traceability down to the sequence level and dashboards that give teams the visibility to move faster.
Explore the possibilities with Benchling Biologics
Run antibody screening campaigns
Screen antibodies generated from hybridomas and primary B-cell cultures as well as arrayed libraries from phage and yeast display technologies. Create standardized experimental plans and study protocols using established Notebook templates.
Perform sequencing and plasmid design
Configure any antibody format in minutes, then register antibodies at scale with automated registration. Move directly into plasmid design, using tools for high-throughput combinatorial assembly to build expression-ready constructs.
Coordinate protein expression and purification runs
Set up protein expression runs quickly using standardized templates. Confirm sequence or sample identity and history with full end-to-end lineage tracking. Analyze and optimize expression parameters with in-platform data visualization.
Characterize in vitro antibody properties
Relay sample information and related results accurately and efficiently between teams. Execute analytical assays quickly and enforce SOPs with protocols and templates. Integrate directly with analytical instruments to centralize all assay results for easy analysis and visualization.
Study pharmacology, safety, and efficacy in vivo
Plan in vivo studies and generate study protocols with collaborative tools. Use Studies to monitor vivarium animals, perform randomization, and collect in-life study measurements and calculations. Automatically link bioanalytical assay results to tissue samples with a unified data model.
Learn about Benchling's antibody and protein R&D solutions
Accelerators
The Antibody and Protein Therapy R&D Accelerators provide best practices that shorten time-to-value for research and process development. The Accelerators contain:
Data model: entity relationship diagram (ERD) which serves as an implementation blueprint
Tenant configuration: pre-defined tenant configuration using templates and dashboards for registering entities, tracking results, increasing inventory utilization, and streamlining workflows
Solution Guide: highlight capabilities and latest product features
Services
Benchling’s services support customers from implementation through ongoing success.
Professional Services: Solution-specific domain expertise to jumpstart your optimal implementation
Customer Success: Continual solution optimization that takes advantage of new feature releases and ongoing industry learning
How we deliver
Dedicated expertise
Our Customer Experience professionals possess deep industry expertise alongside IT best practices. They’ve worked for and with the world’s leading biotech and biopharma companies and have used this know-how to support customers across R&D teams.
Continuous oversight
Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
Focused R&D support
Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support teams across R&D functions.
The timeline is a huge selling point for customers right now … It's a combination of a lot of processes that have improved. But Benchling really enabled that scaled work.
Paul Guyett
Research Group Lead, Invenra
